Answers are grounded in this paper and cite their sources.
Non-small cell lung cancer (NSCLC) remains the leading cause of cancer-related mortality worldwide, largely because its early symptoms are non-specific and diagnosis often occurs at advanced stages. Emerging evidence suggests that alterations in the lung microbiome contribute to NSCLC development and progression. This study evaluated the feasibility of using exhaled breath condensate (EBC) as a non-invasive source of lung microbiome profiles. We performed 16 S rRNA gene metabarcoding on 32 EBC samples and compared their microbial composition with matched tumor and adjacent control lung tissues. EBC provided sufficient bacterial sequence data for 16 S rRNA gene-based microbiome analysis. We found that a limited but detectable proportion of the EBC microbial profile could be attributed to lung-tissue sources, while seven genera were common across all analyzed sample types. Escherichia - Shigella , predominant genus previously linked to lung malignancy, was consistently detectable in EBC. EBC also showed a higher bacterial sequence retention rate suggesting a lower relative impact of host DNA interference. These findings offer a preliminary signal of the feasibility of EBC as a non-invasive material for pulmonary microbiome research. Further studies including healthy controls are required before EBC can be considered for biomarker development or clinical applications.
No takes yet. Share an insight, caveat, or question.
Machnicki et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: